IMO, MM is after another device because wheezo isn't doing as well as he thought since wheezing doesn't mean you are having an Asthma attack or even Asthma. Hence ADR stated is inline with my research of wheezo "The clinical significance of measuring wheeze in the treatment of Asthma and COPD and whether this would qualify for reimbursement, in particular in the US, has currently to Adherium’s knowledge not been independently demonstrated or verified."
Ann: RSH:RPM CPT Reimbursement&response to statements made by ADR, page-6
Add ADR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.8¢ |
Change
-0.001(5.26%) |
Mkt cap ! $7.021M | |||
| Open | High | Low | Value | Volume |
| 1.8¢ | 1.8¢ | 1.8¢ | $112 | 6.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 923950 | 1.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.9¢ | 306753 | 4 |
View Market Depth
| Last trade - 11.50am 15/05/2024 (20 minute delay) ? |
|
|||||
|
Last
1.8¢ |
Change
-0.001 ( 5.26 %) |
||||
| Open | High | Low | Volume | ||
| 1.8¢ | 1.8¢ | 1.8¢ | 143800 | ||
| Last updated 11.49am 15/05/2024 ? | |||||
| ADR (ASX) Chart |